Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 43, 4119-4125, September 1, 1983]
© 1983 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spinelli, W.
Right arrow Articles by Ishii, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spinelli, W.
Right arrow Articles by Ishii, D. N.

Tumor Promoter Receptors Regulating Neurite Formation in Cultured Human Neuroblastoma Cells1

Walter Spinelli2 and Douglas N. Ishii3

Department of Pharmacology and the Cancer Research Center, College of Physicians and Surgeons of Columbia University, New York, New York 10032

The mouse skin tumor promoter phorbol-12, 13-dibutyrate (PDBU) reversibly enhanced neurite outgrowth in SH-SY5Y human neuroblastoma cells, whether serum was present or absent. The half-maximum response in serum occurred at 10 nM. The binding of [20-3H]phorbol-12, 13-dibutyrate ([3H]PDBU) was studied. Five mouse skin tumor promoters, which included teleocidin, mezerein, and three structural congeners of phorbol, enhanced neurite outgrowth and inhibited binding of [3H]PDBU, but two nonpromoting phorbol congeners did neither. Saccharin and cyclamate, promoters in rat bladder, did not inhibit [3H]PDBU binding. Binding of 10 nM [3H]PDBU at 37° was maximal within 5 min and stable for at least 5 hr. Down modulation of binding was not detected. Following binding at 37°, the dissociation rate in excess PDBU was biphasic, whether measured at 37° or at 4°. The Scatchard curve was also consistent with two types of sites, about 2.5 x 105 sites/cell with Kd = 8.6 nM and 1.2 x 106 sites with Kd = 125 nM. Negative cooperativity was not observed. In short-term assays, nerve growth factor (NGF) did not alter [3H]PDBU binding, and phorbol ester promoters did not alter 125I-NGF binding. Furthermore, [3H]PDBU binding was unaltered following growth of cells for 1 week in PDBU or NGF, conditions under which neurite outgrowth was continuously enhanced, and other phenotypic expressions of differentiation are known to be increased. Specific [3H]PDBU binding sites were present in five neuroblastoma cell lines, two of which are responsive and three unresponsive by neurite outgrowth to promoters and NGF, suggesting the possibility of a common lesion in distal steps in the unresponsive lines.

1 Supported in part by Grant R01 NS 14218 from the National Institute of Neurological Communicative Diseases and Stroke.

2 Predoctoral fellow, recipient of support in part from the Dr. and Mrs. S. C. Wang Fund and from USPHS Training Grant GM 07182 from the Division of General Medical Sciences.

3 Recipient of USPHS Research Career Development Award 1K04 NS00375. To whom requests for reprints should be addressed.

Received 3/ 9/83. Accepted 6/ 6/83.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1983 by the American Association for Cancer Research.